Abvc Biopharma (ABVC) Preferred Shares (2010 - 2015)
Abvc Biopharma's (ABVC) quarterly Preferred Shares came in at $1.0 in Q3 2015, little changed on a YoY basis from $1.0 in Q3 2014, and down 100.0% quarter-over-quarter from $10.0 million in Q4 2014.
Analysis
Abvc Biopharma (ABVC) Preferred Shares (2010 - 2015) Analysis & Trends
Abvc Biopharma (ABVC) has reported Preferred Shares for 6 consecutive years, with $1.0 the latest figure, recorded in Q3 2015.
- For the quarter ending Q3 2015, Preferred Shares changed 0.0% year-over-year to $1.0; the trailing twelve-month figure through Sep 2015 stood at $1.0 (changed 0.0% YoY), and the FY2015 full-year result was $1.0, down 100.0% from the prior year.
- Preferred Shares fell to $1.0 in Q3 2015 per ABVC's latest filing, from $10.0 million in the prior quarter.
- Across five years, Preferred Shares topped out at $10.0 million in Q3 2011 and bottomed at $1.0 in Q2 2012.
- Historically, Preferred Shares has averaged $4.5 million across 5 years, with a median of $7.0 in 2011.
- The sharpest annual moves came in 2011 and 2012: Preferred Shares surged 249999900.0% in 2011, then slumped 50.0% in 2012.
- Over 5 years, Preferred Shares stood at $7.0 in 2011, then jumped by 142857042.86% to $10.0 million in 2012, then changed by 0.0% to $10.0 million in 2013, then changed by 0.0% to $10.0 million in 2014, then tumbled by 100.0% to $1.0 in 2015.
- According to Business Quant data, Preferred Shares over the past three periods registered $1.0, $10.0 million, and $1.0 for Q3 2015, Q4 2014, and Q3 2014 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Abvc Biopharma | 25.56 Mn | 25.56 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2015 | 1.00 |
| Dec 31, 2014 | 10.00 Mn |
| Sep 30, 2014 | 1.00 |
| Mar 31, 2013 | 10.00 Mn |
| Dec 31, 2012 | 10.00 Mn |
| Sep 30, 2012 | 10.00 Mn |
| Jun 30, 2012 | 1.00 |
| Mar 31, 2012 | 7.00 |
| Dec 31, 2011 | 7.00 |
| Sep 30, 2011 | 10.00 Mn |
| Jun 30, 2011 | 2.00 |
| Sep 30, 2010 | 4.00 |